• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

替鲁膦酸盐抑制破骨细胞中的蛋白酪氨酸磷酸酶活性。

Tiludronate inhibits protein tyrosine phosphatase activity in osteoclasts.

作者信息

Murakami H, Takahashi N, Tanaka S, Nakamura I, Udagawa N, Nakajo S, Nakaya K, Abe M, Yuda Y, Konno F, Barbier A, Suda T

机构信息

Department of Biochemistry, School of Dentistry, Showa University, Tokyo, Japan.

出版信息

Bone. 1997 May;20(5):399-404. doi: 10.1016/s8756-3282(97)00025-2.

DOI:10.1016/s8756-3282(97)00025-2
PMID:9145236
Abstract

Signaling pathways mediated by tyrosine phosphorylation and dephosphorylation have been reported to be involved in the regulation of cytoskeletal organization in osteoclasts, the principal cells responsible for bone resorption. We examined the effects of tiludronate [(4-chlorophenyl)thiomethylene bisphosphonate] on the cytoskeleton and the balance of phosphotyrosine levels in osteoclast-like multinucleated cells (OCLs) formed in cocultures of mouse osteoblastic cells and bone marrow cells. When OCLs were placed on plastic dishes in the presence of 10% fetal bovine serum, they formed a ringed structure of F-actin dots (actin ring) within 2 h. Tiludronate did not inhibit the process of actin ring formation, but it disrupted preformed actin rings in a time- and a dose-dependent manner. Western blot analysis using an antiphosphotyrosine antibody revealed that tyrosine phosphorylation of certain proteins in OCLs was stimulated by tiludronate added to the purified OCLs. Tyrosine kinase activity of the p60c-src immunoprecipitated from cell lysates of the purified OCLs was not affected by tiludronate directly added to the kinase assay. OCL lysates stimulated dephosphorylation of tyrosine-phosphorylated substrates such as phosphoneuroprotein 14 and epidermal growth factor receptors. Like sodium orthovanadate, an inhibitor of protein tyrosine phosphatases, tiludronate dose-dependently inhibited tyrosine dephosphorylation of those substrates induced by OCL lysates. These findings suggest that tiludronate disrupts the preformed actin rings and suppresses bone-resorbing activity by inhibiting protein tyrosine phosphatases in osteoclasts.

摘要

据报道,由酪氨酸磷酸化和去磷酸化介导的信号通路参与破骨细胞(负责骨吸收的主要细胞)中细胞骨架组织的调节。我们研究了替鲁膦酸盐[(4-氯苯基)硫亚甲基双膦酸盐]对在小鼠成骨细胞和骨髓细胞共培养中形成的破骨细胞样多核细胞(OCLs)的细胞骨架和磷酸酪氨酸水平平衡的影响。当OCLs在10%胎牛血清存在下置于塑料培养皿中时,它们在2小时内形成了F-肌动蛋白点的环状结构(肌动蛋白环)。替鲁膦酸盐不抑制肌动蛋白环的形成过程,但它以时间和剂量依赖的方式破坏预先形成的肌动蛋白环。使用抗磷酸酪氨酸抗体的蛋白质免疫印迹分析显示,添加到纯化的OCLs中的替鲁膦酸盐刺激了OCLs中某些蛋白质的酪氨酸磷酸化。从纯化的OCLs细胞裂解物中免疫沉淀的p60c-src的酪氨酸激酶活性不受直接添加到激酶测定中的替鲁膦酸盐的影响。OCLs裂解物刺激了酪氨酸磷酸化底物如神经磷酸蛋白14和表皮生长因子受体的去磷酸化。与蛋白质酪氨酸磷酸酶抑制剂原钒酸钠一样,替鲁膦酸盐剂量依赖性地抑制了由OCLs裂解物诱导的这些底物的酪氨酸去磷酸化。这些发现表明,替鲁膦酸盐通过抑制破骨细胞中的蛋白质酪氨酸磷酸酶来破坏预先形成的肌动蛋白环并抑制骨吸收活性。

相似文献

1
Tiludronate inhibits protein tyrosine phosphatase activity in osteoclasts.替鲁膦酸盐抑制破骨细胞中的蛋白酪氨酸磷酸酶活性。
Bone. 1997 May;20(5):399-404. doi: 10.1016/s8756-3282(97)00025-2.
2
A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders.双膦酸盐对破骨细胞的特异性作用的一种可能机制:替鲁膦酸优先影响具有皱褶缘的极化破骨细胞。
Bone. 1995 Aug;17(2):137-44. doi: 10.1016/s8756-3282(95)00150-6.
3
Role of c-Src in cellular events associated with colony-stimulating factor-1-induced spreading in osteoclasts.c-Src在与集落刺激因子-1诱导破骨细胞铺展相关的细胞事件中的作用。
Mol Reprod Dev. 1997 Jan;46(1):104-8. doi: 10.1002/(SICI)1098-2795(199701)46:1<104::AID-MRD16>3.0.CO;2-2.
4
Tyrosine phosphorylation of p130Cas is involved in actin organization in osteoclasts.p130Cas的酪氨酸磷酸化参与破骨细胞的肌动蛋白组织。
J Biol Chem. 1998 May 1;273(18):11144-9. doi: 10.1074/jbc.273.18.11144.
5
The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: increased resorption and osteopenia in me(v)/me(v) mutant mice.酪氨酸磷酸酶SHP-1是破骨细胞生成和破骨细胞吸收活性的负调节因子:me(v)/me(v)突变小鼠中吸收增加和骨质减少。
Bone. 1999 Sep;25(3):261-7. doi: 10.1016/s8756-3282(99)00174-x.
6
Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption.渥曼青霉素,一种磷脂酰肌醇-3激酶的特异性抑制剂,可阻断破骨细胞介导的骨吸收。
FEBS Lett. 1995 Mar 13;361(1):79-84. doi: 10.1016/0014-5793(95)00153-z.
7
[Possible mechanism of the specific action of bisphosphonates on osteoclasts].[双膦酸盐对破骨细胞特异性作用的可能机制]
Nihon Rinsho. 2003 Feb;61(2):207-12.
8
Activation of Src kinase by protein-tyrosine phosphatase-PEST in osteoclasts: comparative analysis of the effects of bisphosphonate and protein-tyrosine phosphatase inhibitor on Src activation in vitro.破骨细胞中蛋白酪氨酸磷酸酶-PEST对Src激酶的激活作用:双膦酸盐和蛋白酪氨酸磷酸酶抑制剂对体外Src激活作用的比较分析
J Cell Physiol. 2009 Aug;220(2):382-93. doi: 10.1002/jcp.21777.
9
Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts.降钙素诱导的细胞骨架变化是由破骨细胞中与蛋白激酶A相关的信号通路介导的。
Endocrinology. 1996 Nov;137(11):4685-90. doi: 10.1210/endo.137.11.8895334.
10
Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts.美伐他汀通过抑制前融合破骨细胞的融合和破坏破骨细胞中的肌动蛋白环来抑制骨吸收。
J Bone Miner Res. 2000 Apr;15(4):650-62. doi: 10.1359/jbmr.2000.15.4.650.

引用本文的文献

1
Skeletal metastasis: treatments, mouse models, and the Wnt signaling.骨转移:治疗方法、小鼠模型与Wnt信号通路
Chin J Cancer. 2013 Jul;32(7):380-96. doi: 10.5732/cjc.012.10218. Epub 2013 Jan 18.
2
Tiludronate treatment improves structural changes and symptoms of osteoarthritis in the canine anterior cruciate ligament model.替鲁膦酸盐治疗可改善犬前交叉韧带模型骨关节炎的结构变化和症状。
Arthritis Res Ther. 2011 Jun 21;13(3):R98. doi: 10.1186/ar3373.
3
Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells.
无类固醇培养基揭示了双膦酸盐氯膦酸盐对乳腺癌细胞的雌激素样作用。
Br J Cancer. 2004 Nov 1;91(9):1703-10. doi: 10.1038/sj.bjc.6602181.
4
Tyrosine phosphatase epsilon is a positive regulator of osteoclast function in vitro and in vivo.酪氨酸磷酸酶ε在体外和体内均是破骨细胞功能的正向调节因子。
Mol Biol Cell. 2004 Jan;15(1):234-44. doi: 10.1091/mbc.e03-04-0207. Epub 2003 Oct 3.
5
Beta-hydroxyisovalerylshikonin is a novel and potent inhibitor of protein tyrosine kinases.β-羟基异戊酰紫草素是一种新型强效蛋白酪氨酸激酶抑制剂。
Jpn J Cancer Res. 2002 Aug;93(8):944-51. doi: 10.1111/j.1349-7006.2002.tb01341.x.
6
Drugs in development: bisphosphonates and metalloproteinase inhibitors.正在研发的药物:双膦酸盐和金属蛋白酶抑制剂。
Arthritis Res Ther. 2003;5(1):12-24. doi: 10.1186/ar604. Epub 2002 Nov 8.
7
Bisphosphonate mechanism of action.双膦酸盐的作用机制。
Curr Rheumatol Rep. 2003 Feb;5(1):65-74. doi: 10.1007/s11926-003-0085-6.
8
Relationship between bisphosphonate concentration and osteoclast activity and viability.
In Vitro Cell Dev Biol Anim. 1999 Jul-Aug;35(7):383-8. doi: 10.1007/s11626-999-0112-7.